Literature DB >> 31765783

Development of novel bilayer gastroretentive tablets based on hydrophobic polymers.

Thi-Tram Nguyen1, Kyu-Mok Hwang1, Su-Hyeon Kim1, Eun-Seok Park2.   

Abstract

This study aimed to develop a bilayer gastroretentive (GR) tablet containing an insoluble drug and ascertain the potential of using hydrophobic polymers in GR matrix systems. Highly porous tablets were prepared using a camphor-based sublimation technique. After the screening of several commonly used polymers, two types of GR layers, a conventional hydrophilic GR layer and a hydrophobic GR layer, were designed. The optimal drug layer comprising Metolose® 90SH-100SR and dicalcium phosphate provided not only a gradual matrix erosion but also high strength after hydration. Regarding the GR layers, the hydrophobic layer based on Kollidon® SR was superior to the hydrophilic layer made of PEO 7 M in terms of wet strength, implying a higher resistance to mechanical stresses upon water absorption. Also, the excellent tableting properties of Kollidon® SR and the effects of curing in improving its matrix hardness resulted in porous tablets with better mechanical strength. Moreover, good flowability and low cohesion of Kollidon® SR formulation were advantageous in direct compression. In conclusion, novel bilayer GR tablets were successfully developed, indicating the potential for widening the application of GR systems to insoluble drugs. The results also suggested numerous advantages of incorporating Kollidon® SR into the production of GR tablets.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bilayer tablets; Erosion-based controlled release; Gastroretentive tablets; Gel strength; Hydrophobic matrix formers; Rebamipide

Mesh:

Substances:

Year:  2019        PMID: 31765783     DOI: 10.1016/j.ijpharm.2019.118865

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  1 in total

1.  Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®.

Authors:  Yoshihiro Omachi
Journal:  AAPS PharmSciTech       Date:  2022-06-08       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.